These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21285972)

  • 1. The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue.
    Oladipo O; Conlon S; O'Grady A; Purcell C; Wilson C; Maxwell PJ; Johnston PG; Stevenson M; Kay EW; Wilson RH; Waugh DJ
    Br J Cancer; 2011 Feb; 104(3):480-7. PubMed ID: 21285972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma.
    Eck M; Schmausser B; Scheller K; Brändlein S; Müller-Hermelink HK
    Clin Exp Immunol; 2003 Dec; 134(3):508-15. PubMed ID: 14632759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ELR+ CXC chemokine expression in benign and malignant colorectal conditions.
    Rubie C; Frick VO; Wagner M; Schuld J; Gräber S; Brittner B; Bohle RM; Schilling MK
    BMC Cancer; 2008 Jun; 8():178. PubMed ID: 18578857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of the prognosis and immune infiltration for CXC chemokines in colorectal cancer.
    Yang X; Wei Y; Sheng F; Xu Y; Liu J; Gao L; Yang J; Sun X; Huang J; Guo Q
    Aging (Albany NY); 2021 Jul; 13(13):17548-17567. PubMed ID: 34233297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of SMAD4 Promotes Colorectal Cancer Progression by Recruiting Tumor-Associated Neutrophils via the CXCL1/8-CXCR2 Axis.
    Ogawa R; Yamamoto T; Hirai H; Hanada K; Kiyasu Y; Nishikawa G; Mizuno R; Inamoto S; Itatani Y; Sakai Y; Kawada K
    Clin Cancer Res; 2019 May; 25(9):2887-2899. PubMed ID: 30705034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a hellenic cooperative oncology group randomised trial.
    Pentheroudakis G; Raptou G; Kotoula V; Wirtz RM; Vrettou E; Karavasilis V; Gourgioti G; Gakou C; Syrigos KN; Bournakis E; Rallis G; Varthalitis I; Galani E; Lazaridis G; Papaxoinis G; Pectasides D; Aravantinos G; Makatsoris T; Kalogeras KT; Fountzilas G
    PLoS One; 2015; 10(5):e0124612. PubMed ID: 25970543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of the expression and prognostic value of CXC chemokines in colorectal cancer.
    Yu L; Yang X; Xu C; Sun J; Fang Z; Pan H; Han W
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107077. PubMed ID: 33068862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL8 expression is associated with advanced stage, right sidedness, and distinct histological features of colorectal cancer.
    Pennel KA; Quinn JA; Nixon C; Inthagard J; van Wyk HC; Chang D; Rebus S; ; Hay J; Maka NN; Roxburgh CS; Horgan PG; McMillan DC; Park JH; Roseweir AK; Steele CW; Edwards J
    J Pathol Clin Res; 2022 Nov; 8(6):509-520. PubMed ID: 35879507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal Expression of Vimentin Predicts the Clinical Outcome of Stage II Colorectal Cancer for High-Risk Patients.
    Liu LG; Yan XB; Xie RT; Jin ZM; Yang Y
    Med Sci Monit; 2017 Jun; 23():2897-2905. PubMed ID: 28611349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer.
    Cabrero-de Las Heras S; Martínez-Balibrea E
    World J Gastroenterol; 2018 Nov; 24(42):4738-4749. PubMed ID: 30479461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of CXC subfamily ligands in stage I-III patients with colorectal cancer.
    Li X; Zhong Q; Luo D; Du Q; Liu W
    PLoS One; 2019; 14(4):e0214611. PubMed ID: 30973890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer.
    Yamamoto Y; Kuroda K; Sera T; Sugimoto A; Kushiyama S; Nishimura S; Togano S; Okuno T; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Ohira M; Yashiro M
    Anticancer Res; 2019 Dec; 39(12):6645-6652. PubMed ID: 31810929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine (C-X-C motif) ligand 1 is associated with tumor progression and poor prognosis in patients with colorectal cancer.
    Zhuo C; Wu X; Li J; Hu D; Jian J; Chen C; Zheng X; Yang C
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29784873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPARC, FOXP3, CD8 and CD45 correlation with disease recurrence and long-term disease-free survival in colorectal cancer.
    Chew A; Salama P; Robbshaw A; Klopcic B; Zeps N; Platell C; Lawrance IC
    PLoS One; 2011; 6(7):e22047. PubMed ID: 21818290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine CXCL14 is associated with prognosis in patients with colorectal carcinoma after curative resection.
    Zeng J; Yang X; Cheng L; Liu R; Lei Y; Dong D; Li F; Lau QC; Deng L; Nice EC; Xie K; Huang C
    J Transl Med; 2013 Jan; 11():6. PubMed ID: 23294544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of CXC-chemokines and CXC-chemokine receptor type II constitute an autocrine growth mechanism in the epidermoid carcinoma cells KB and A431.
    Metzner B; Hofmann C; Heinemann C; Zimpfer U; Schraufstätter I; Schöpf E; Norgauer J
    Oncol Rep; 1999; 6(6):1405-10. PubMed ID: 10523720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of CXCL1 hypersecretion by human colorectal cancer epithelia and myofibroblasts.
    le Rolle AF; Chiu TK; Fara M; Shia J; Zeng Z; Weiser MR; Paty PB; Chiu VK
    J Transl Med; 2015 Jun; 13():199. PubMed ID: 26104296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXC chemokines located in the 4q21 region are up-regulated in breast cancer.
    Bièche I; Chavey C; Andrieu C; Busson M; Vacher S; Le Corre L; Guinebretière JM; Burlinchon S; Lidereau R; Lazennec G
    Endocr Relat Cancer; 2007 Dec; 14(4):1039-52. PubMed ID: 18045955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of CXC group chemokines in lung cancer development and progression.
    Spaks A
    J Thorac Dis; 2017 Apr; 9(Suppl 3):S164-S171. PubMed ID: 28446981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen alpha (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2.
    Catusse J; Liotard A; Loillier B; Pruneau D; Paquet JL
    Biochem Pharmacol; 2003 Mar; 65(5):813-21. PubMed ID: 12628493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.